title: Management of neonatal abstinence syndrome in the newborn nursery.
abstract: Maternal drug use and neonatal abstinence syndrome (NAS) are being seen across the United States. NAS occurs with withdrawal disturbances in response to the cessation of the pregnancy exposure. The clinical presentation of a newborn with NAS can include gastrointestinal, neurologic, vasomotor and respiratory symptoms. Assessment of newborns with NAS can often present as a challenge to maternal-child nurses. Treatment can include supportive care as well as pharmacologic therapies.
authors.forename: Valarie
authors.initials: V
authors.lastname: Artigas
mesh_terms: D005260:Female; D006801:Humans; D007231:Infant, Newborn; D008691:Methadone / Q000009:adverse effects / Q000627:therapeutic use*; D009034:Mother-Child Relations; D009357:Neonatal Abstinence Syndrome / Q000188:drug therapy*; D011247:Pregnancy; D011248:Pregnancy Complications / Q000188:drug therapy* / Q000534:rehabilitation; D011297:Prenatal Exposure Delayed Effects / Q000188:drug therapy; D019966:Substance-Related Disorders / Q000150:complications; D014481:United States
chemical_list: D008691:Methadone
keywords: SSRI; maternal drug use; neonatal abstinence syndrome; non-opioid; opioid